Latest News

Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures

IRVINE, Calif.–(BUSINESS WIRE)–Biogennix has received FDA clearance for expanded use of its Agilon moldable bone grafting solution in spine procedures.

Source link

Related posts

How one company thinks unraveling cough can provide a new way to treat pain


Fact-check: Who’s right on protections for preexisting conditions? It’s complicated


Is The Word 'Pet' Patronizing Our Animal Friends? PETA Thinks So


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy